Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04715451
Other study ID # IRB00261157
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date May 2027

Study information

Verified date March 2024
Source Johns Hopkins University
Contact Lauren Jantzie, PhD
Phone 410-614-4135
Email LJantzie@jhmi.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will test a new medical grade swaddling system for optimal and more appropriate positioning for preterm infants. This is a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development.


Description:

Throughout pregnancy, the fetus is encouraged to develop by maintaining proper flexed posture in the uterus and freely moving its arms and legs against the flexible boundaries of the womb. However, when born too early, preterm infants lose the natural boundaries of the womb that support this flexor positioning and movement support. In addition preterm infants undergo stress because of essential treatments in neonatal intensive care units and exposure to the extrauterine environment. To support the development of preterm infants, cotton wraps are often used to maintain appropriate body positioning. Swaddling helps maintain continuous and adequate body positioning which aids and provides a stable sleep environment and encourages muscle tone. However, traditional swaddling is challenging in preterm infants and preterm infants frequently become unswaddled. It is fraught with difficulties related to the neonatal care and monitoring preterm infants receive due to the prematurity. In addition, this stiff material does not provide the same sensory experience as the flexible boundaries of the womb. In response to this challenge, The Investigators developed a new medical grade swaddling system for optimal and more appropriate positioning and natural movement. Here, The Investigators outline a trial focused on sleep state, state regulation and long-term neurodevelopment. The central hypothesis is that this novel swaddling method will promote sleep and an optimal sleep-wake cycle, while also improving the neurodevelopment of preterm infants. It is proposed that adequate positioning and secondary feedback of natural movement of arms and legs stimulates and fosters normal brain development. The Investigators will clinically evaluate sleep at the level of amplitude-integrated electroencephalograph (aEEG) activity and perform the Prechtl's Assessment of General Movements (GMA) to assess spontaneous writhing and fidgety movements, which predicts the future neurodevelopment of preterm babies. The Investigators will also perform the Neonatal Intensive Care Unit (NICU) Network Neurobehavioural Scale (NNNS) as a standardized assessment of neurological integrity and organization. The goal is to provide early intervention to improve development in preterm infants.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date May 2027
Est. primary completion date May 2026
Accepts healthy volunteers No
Gender All
Age group 24 Weeks to 37 Weeks
Eligibility Inclusion Criteria: - Born very preterm (<32 weeks postmenstrual age (PMA)) - At least 12 hours and less than 2 months old - Expected to survive > 3 days - No congenital anomaly or genetic disorder with expected survival less than term equivalent - No malformations requiring surgery within 1 month of life - Central intravenous lines removed - Approval of the primary neonatologist, ideally not a study team member, to approach family for consent - Appropriate parent or guardian to provide informed consent Exclusion Criteria: - Life expectancy < 3 days - Severe congenital anomaly or genetic disorder with life expectancy <40 weeks PMA - Seizures - Need for seizure medication - Hypertension for age requiring medication - Severe hematologic crisis such as disseminated intravascular coagulation - Hydrops fetalis - Clinical concern or diagnosis of toxoplasmosis, cytomegalovirus rubella or syphilis infection - Clinical concern or diagnosis of severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2) or coronavirus disease (COVID-19) - Central intravenous access and reliance on parenteral nutrition >50% - Respiratory support greater than nasal canulae or nasal continuous positive airway pressure (CPAP) (i.e. ventilator dependent) - Active infection, including need for antibiotics greater than 5 days (i.e. confirmed infection) - Complex congenital heart disease - Known chromosomal abnormalities - Clinical or echocardiographic signs of symptomatic pulmonary hypertension - Profound perinatal hypoxia-ischemia - Receiving treatment for pain control - Sustained tachypnea >80 breaths/minute - Need for volume expansion or administration of inotropes - No one available or willing to provide consent

Study Design


Intervention

Other:
Novel Swaddle
A novel swaddling method.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University The Thomas Wilson Sanitarium for Children of Baltimore City

References & Publications (1)

Kitase Y, Sato Y, Takahashi H, Shimizu M, Ishikawa C, Yamamoto H, Hayakawa M. A new type of swaddling clothing improved development of preterm infants in neonatal intensive care units. Early Hum Dev. 2017 Sep;112:25-28. doi: 10.1016/j.earlhumdev.2017.06.005. Epub 2017 Jul 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Sleep-Wake Cycling Maturity as assessed by amplitude integrated EEG (aEEG) readings Using aEEG, the Investigators will assess the presence or absence of mature sleep-wake cycling as defined as regular rhythmic sinusoidal variations of amplitude with a cycle greater than or equal to 20 minutes. Tracings with a cycling pattern that does not fit into a mature sleep-wake cycle for the majority of the tracing will be classified as intermediate. 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Primary Change in length of time spent in sleep Using aEEG, the Investigators will assess the change in length of time (in minutes) spent in sleep. 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Primary Change in the number of awakenings in a 3 hour time period Using aEEG, the Investigators will assess the change in number of awakenings in a 3 hour time period. 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Primary Change in voltage as assessed by aEEG) readings Using aEEG, the Investigators will assess the change in voltage (measured in microvolts). 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Primary Change in ratio of active sleep and quiet sleep as assessed by amplitude integrated EEG (aEEG) readings Using aEEG The Investigators will assess the time spent in active sleep (irregular and low in amplitude) and quiet sleep (regular and high in amplitude). 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Primary Change in Sleep-Wake Cycling Continuity as assessed by amplitude integrated EEG (aEEG) readings Using aEEG The Investigators will examine the background activity on recordings to assess the presence or absence of isoelectric periods along with amplitude fluctuations. Tracings will be classified as continuous, discontinuous and borderline. 32 weeks postmenstrual age, 34 weeks postmenstrual age and 36 weeks postmenstrual age
Secondary Behavioral Maturity as assessed by the NNNS The NICU Network Neurobehavioural Scale (NNNS) is a standardized clinical assessment tool used to assess neurological integrity and organization in a single, structured clinical exam. Summary scores are created for neurobehavioral domains including: habituation, attention, handling, quality of movement, self-regulation, non optimal reflexes, asymmetrical reflexes, stress/abstinence, arousal, hypertonicity, excitability, and lethargy. 13 summary scores will be generated. 37 weeks postmenstrual age
Secondary Change in General Movements as assessed by the GMA Prechtl's General Movement Assessment (GMA) is a clinical assessment tool that classifies writhing movements in preterm infants. Specifically, classification of writhing movements will be made as cramped synchronous, poor repertoire with cramped synchronicity, or poor repertoire. 32 weeks postmenstrual age and 37 weeks postmenstrual age
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns